MariMed, Inc. has embarked on a remarkable journey, boasting a 48% increase in wholesale revenue in 2023 and projecting over 20% growth for 2024. Under the leadership of CEO Jon Levine, the company has navigated through regulatory uncertainties and competitive market headwinds with strategic expansions and product innovation. So, how did they achieve such success in the fiercely competitive cannabis industry? The secret behind MariMed’s impressive trajectory and the insights into its future strategies can be discovered firsthand at the Benzinga Cannabis Capital Conference. Scheduled for April …
